BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34446997)

  • 1. Evaluating the Role of HLA DRB1 Alleles and Oligoclonal Bands in Influencing Clinical Course of Multiple Sclerosis - A Study from the Mangalore Demyelinating Disease Registry.
    DCunha A; Pandit L; Malli C; Sudhir A
    Ann Indian Acad Neurol; 2021; 24(3):356-360. PubMed ID: 34446997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability.
    Balnytė R; Rastenytė D; Ulozienė I; Mickevičienė D; Skordenienė E; Vitkauskienė A
    Medicina (Kaunas); 2011; 47(7):368-73. PubMed ID: 22112985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.
    Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T
    Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
    Mero IL; Gustavsen MW; Sæther HS; Flåm ST; Berg-Hansen P; Søndergaard HB; Jensen PE; Berge T; Bjølgerud A; Muggerud A; Aarseth JH; ; Myhr KM; Celius EG; Sellebjerg F; Hillert J; Alfredsson L; Olsson T; Oturai AB; Kockum I; Lie BA; Andreassen BK; Harbo HF
    PLoS One; 2013; 8(3):e58352. PubMed ID: 23472185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
    Balnyte R; Rastenyte D; Vaitkus A; Mickeviciene D; Skrodeniene E; Vitkauskiene A; Uloziene I
    BMC Neurol; 2013 Jul; 13():77. PubMed ID: 23837503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen.
    Kikuchi S; Fukazawa T; Niino M; Yabe I; Miyagishi R; Hamada T; Hashimoto SA; Tashiro K
    Neurology; 2003 Feb; 60(4):647-51. PubMed ID: 12601107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
    Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
    J Neuroimmunol; 2013 Jan; 254(1-2):170-3. PubMed ID: 22967351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
    J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
    Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
    Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.
    Leone MA; Barizzone N; Esposito F; Lucenti A; Harbo HF; Goris A; Kockum I; Oturai AB; Celius EG; Mero IL; Dubois B; Olsson T; Søndergaard HB; Cusi D; Lupoli S; Andreassen BK; ; ; Myhr KM; Guerini FR; ; ; Comi G; Martinelli-Boneschi F; D'Alfonso S
    PLoS One; 2013; 8(6):e64408. PubMed ID: 23785401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.
    Gustavsen MW; Viken MK; Celius EG; Berge T; Mero IL; Berg-Hansen P; Aarseth JH; Myhr KM; Søndergaard HB; Sellebjerg F; Oturai AB; Hillert J; Alfredsson L; Olsson T; Kockum I; Lie BA; Harbo HF
    J Neuroimmunol; 2014 Sep; 274(1-2):174-9. PubMed ID: 25037176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K; Landtblom AM; Hillert J; Masterman T
    Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
    Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J
    Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.